PAPER Xavier-de-Britto I, Gomes-da-Silva NC, Gomes Soares MA, Follmer C, Dabkiewicz D, Alencar LM, Sant'Anna C, Ferreira TP, Martins PM, Ricci-Junior E, Fechine PB, Santos-Oliveira R

Therapeutic Potential of Arimoclomol Nanomicelles: In Vitro Impact on Alzheimer's and Parkinson's Pathology and Correlation with In Vivo Inflammatory Response.

ACS Chem Neurosci. 2025 Feb 5; Epub 2025 Feb 5 PubMed.

PAPER Santhanakrishnan A, Tan YJ, Saffari SE, Zhao Y, Ng EY, Ng SY, Chia NS, Choi X, Heng D, Neo S, Xu Z, Tay KY, Au WL, Tan EK, Tan LC, Ng AS

Carriers of Parkinson's disease-linked SNCA Rep1 variant have greater non-motor decline: a 4 year follow up study.

Aging (Albany NY). 2025 Feb 3;null Epub 2025 Feb 3 PubMed.

PAPER Nakamura M, Murakami A, Dickson DW, Yakushiji Y

Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease.

J Neuropathol Exp Neurol. 2025 Feb 5; Epub 2025 Feb 5 PubMed.

PAPER Allerton SC, Kuimova MK, Aprile FA

Molecular Rotors Detect the Formation and Conversion of α-Synuclein Oligomers.

ACS Appl Mater Interfaces. 2025 Feb 5; Epub 2025 Feb 5 PubMed.

PAPER Garcia-Gomara M, Legarra-Marcos N, Serena M, Rojas-de-Miguel E, Espelosin M, Marcilla I, Perez-Mediavilla A, Luquin MR, Lanciego JL, Burrel MA, Cuadrado-Tejedor M, Garcia-Osta A

FKBP5 Inhibition Ameliorates Neurodegeneration and Motor Dysfunction in the Neuromelanin-SNCA Mouse Model of Parkinson's Disease.

Mol Ther. 2025 Feb 3; Epub 2025 Feb 3 PubMed.

Go to another page:

14
15
16
17
18
... 23071

Current Filters

No filters selected

SEARCH RESULTS

Therapeutic effect of dihydroartemisinin on Alzheimer's disease model mice with senile macular degeneration.

Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer's disease.

Revealing the mechanism of two rimantadine derivatives inhibiting Aβ aggregation and destabilizing Aβ protofibrils by molecular dynamics simulation.

The shared mechanism of barrier dysfunction in ulcerative colitis and Alzheimer's disease: DDIT4/IL1β neutrophil extracellular traps drive macrophages-mediated phagocytosis.

RETRACTED: Mano, T. Application of Repetitive Transcranial Magnetic Stimulation over the Dorsolateral Prefrontal Cortex in Alzheimer's Disease: A Pilot Study. J. Clin. Med. 2022, 11, 798.

Triple-Target Inhibition of Cholinesterase, Amyloid Aggregation, and GSK3β to Ameliorate Cognitive Deficits and Neuropathology in the Triple-Transgenic Mouse Model of Alzheimer's Disease.

Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge.

Retraction Notice to: Lentivirus Mediated Delivery of Neurosin Promotes Clearance of Wild-type α-Synuclein and Reduces the Pathology in an α-Synuclein Model of LBD.

Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophy.

Impaired Mitochondrial Function and Ubiquitin Proteasome System Activate α-Synuclein Aggregation in Zinc-Induced Neurotoxicity: Effect of Antioxidants.